The investments Mayo, Mass General and Cedars-Sinai made in 2022

Here are some of the investments Cedars-Sinai Health Ventures, Mayo Clinic Ventures and Mass General Brigham Ventures made in 2022: 

Cedars-Sinai Health (Los Angeles):

1. Cedars-Sinai participated in a $46 million series B financing round for Fathom, a medical coding automation company.
2. Vita Therapeutics, a company using cellular therapeutics to treat muscular dystrophy and cancer, received backing from Cedars-Sinai in a $31 million series B financing round.
3. In July, Cedars-Sinai contributed to the $135 million financing round for diagnostics company Visby Medical.
4. Cedars-Sinai participated in a $30 million funding round for Diligent Robotics, a service robot startup.

Mayo Clinic (Rochester, Minn):

1. Mayo Clinic helped launch fertility company Turtle Health by participating in a $5.4 million financing round. 
2. The health system led a $1 million financing round for Patient Co., a company developing a patient moving tool.
3. Mayo Clinic participated in a $7.3 million seed funding round Olive Diagnostics, a urinalysis company.
4. Sendra Biosciences, a biotech company, received backing from Mayo Clinic in its $123 million series C financing round.
5. In August, Mayo Clinic backed Diagnostic Robotics in a $45 million series B financing round. 

Mass General Brigham (Boston):

1. Mass General joined a $20 million series B financing round for clinical data company Carta Healthcare.
2. The health system’s venture arm participated in a $26 million financing round for InStride Health, a virtual pediatric mental health company.
3. In July, Mass General backed a $32 million seed funding round for Rippl, a mental health company focused on treating older adults.
4. Mass General financed part of digital health company DexCare’s $50 million series B round.